PMO Interview with the Innovator Series: Volume 2

Peter Hirth, PhD
Video Categories: PMO Interview with the Innovator Series

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
September 20, 2013

The Pricing Evolution of Personalized Medicines

Grant Lawless discusses the changing landscape of pricing personalized medicines

October 16, 2015

Anti-CTLA4 vs. Anti-PD-1

Dr. Sanjiv Agarwala examines the benefits of anti-PD-1 therapy vs. anti-CTLA4 therapy and how these therapies may be used on their own and in combination with each other in the future.